194 related articles for article (PubMed ID: 38279058)
21. Immune thrombocytopenia with clinical significance in systemic lupus erythematosus: a retrospective cohort study of 90 patients.
Roussotte M; Gerfaud-Valentin M; Hot A; Audia S; Bonnotte B; Thibault T; Lobbes H; Le Guenno G; Goulabchand R; Cathebras P; Varron L; Dufour JF; Deroux A; Compain C; Baudet A; Karkowski L; Pérard L; Ebbo M; Lega JC; Sève P
Rheumatology (Oxford); 2022 Aug; 61(9):3627-3639. PubMed ID: 34918048
[TBL] [Abstract][Full Text] [Related]
22. Sequential treatment of rituximab and belimumab in thrombotic thrombocytopenia purpura associated with systemic lupus erythematous: A respective case series and literature review.
Liu J; Yan M; Wen R; Li J
Int J Rheum Dis; 2023 May; 26(5):960-964. PubMed ID: 36592434
[TBL] [Abstract][Full Text] [Related]
23. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
[TBL] [Abstract][Full Text] [Related]
24. Rituximab for children with immune thrombocytopenia: a systematic review.
Liang Y; Zhang L; Gao J; Hu D; Ai Y
PLoS One; 2012; 7(5):e36698. PubMed ID: 22666325
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of rituximab in refractory pediatric systemic lupus erythematosus nephritis: a single-center experience of Northern Greece.
Trachana M; Koutsonikoli A; Farmaki E; Printza N; Tzimouli V; Papachristou F
Rheumatol Int; 2013 Mar; 33(3):809-13. PubMed ID: 22101555
[TBL] [Abstract][Full Text] [Related]
26. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
Kumar S; Benseler SM; Kirby-Allen M; Silverman ED
Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
[TBL] [Abstract][Full Text] [Related]
27. Purtscher-like retinopathy associated with systemic lupus erythematosus treated with rituximab plus low-dose interleukin-2: A case report.
Li M; Jin Y; He J
Int J Rheum Dis; 2023 Jul; 26(7):1373-1376. PubMed ID: 36806905
[TBL] [Abstract][Full Text] [Related]
28. Lupus thrombocytopenia: pathogenesis and therapeutic implications.
Galanopoulos N; Christoforidou A; Bezirgiannidou Z
Mediterr J Rheumatol; 2017 Mar; 28(1):20-26. PubMed ID: 32185250
[TBL] [Abstract][Full Text] [Related]
29. Reprint of: B cell elimination in systemic lupus erythematosus. Clin. Immunol. 146(2) 90-103.
Furtado J; Isenberg DA
Clin Immunol; 2013 Sep; 148(3):344-58. PubMed ID: 23642318
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of refractory thrombocytopenia with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Chang HK
J Korean Med Sci; 2005 Oct; 20(5):883-5. PubMed ID: 16224167
[TBL] [Abstract][Full Text] [Related]
31. Novel Mutations in ACP5 and SAMHD1 in a Patient With Pediatric Systemic Lupus Erythematosus.
Hong SM; Chen W; Feng J; Dai D; Shen N
Front Pediatr; 2022; 10():885006. PubMed ID: 35633950
[TBL] [Abstract][Full Text] [Related]
32. Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus.
So MW; Koo BS; Kim YJ; Kim YG; Lee CK; Yoo B
Mod Rheumatol; 2014 Sep; 24(5):855-7. PubMed ID: 24517558
[TBL] [Abstract][Full Text] [Related]
33. Immune thrombocytopenia and COVID-19: Case report and review of literature.
Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
[TBL] [Abstract][Full Text] [Related]
34. Current role of rituximab in systemic lupus erythematosus.
Mok CC
Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
[TBL] [Abstract][Full Text] [Related]
35. Refractory Acquired Amegakaryocytic Thrombocytopenia with Rapid Progression to Aplastic Anaemia in SLE.
Hadid B; Kodza A; Suresh SC; Feoktistov A
Mediterr J Rheumatol; 2023 Dec; 34(4):537-543. PubMed ID: 38282948
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.
Samuel H; Nardi M; Karpatkin M; Hart D; Belmont M; Karpatkin S
Br J Haematol; 1999 Jun; 105(4):1086-91. PubMed ID: 10554825
[TBL] [Abstract][Full Text] [Related]
37. Eltrombopag as steroid sparing therapy for immune thrombocytopenic purpura in systemic lupus erythematosus.
Maroun MC; Ososki R; Andersen JC; Dhar JP
Lupus; 2015 Jun; 24(7):746-50. PubMed ID: 25416695
[TBL] [Abstract][Full Text] [Related]
38. Case report on the use of canakinumab for treatment of recurrent fevers and proteinuria in refractory systemic lupus erythematosus.
Yavari K; Grisanti J
Ther Adv Rare Dis; 2023; 4():26330040231191141. PubMed ID: 37664761
[TBL] [Abstract][Full Text] [Related]
39. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
40. A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus.
Tanaka Y; Yamamoto K; Takeuchi T; Nishimoto N; Miyasaka N; Sumida T; Shima Y; Takada K; Matsumoto I; Saito K; Koike T
Mod Rheumatol; 2007; 17(3):191-7. PubMed ID: 17564773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
